Immunohistochemical measurement of endothelial cell apoptosis and proliferation in formalin-fixed, paraffin-embedded human cancer tissue

被引：4
作者：
Chalmers C.R. [1 ]
Fenwick S.W. [1 ]
Toogood G.J. [2 ]
Hull M.A. [1 ]
机构：
[1] Section of Molecular Gastroenterology, University of Leeds, St. James's University Hospital
[2] Department of Hepatobiliary Surgery, St. James's University Hospital
来源：
Angiogenesis | 2006年 / 9卷 / 4期
基金：
英国医学研究理事会;
关键词：
Angiogenesis; Apoptosis; Cyclooxygenase-2; Endothelial cell; Immunohistochemistry; Microvessel density; Proliferation;
D O I：
10.1007/s10456-006-9050-0
中图分类号：
学科分类号：
摘要：
There is a need for simple, reproducible methodology for measurement of endothelial cell (EC) apoptosis and proliferation in formalin-fixed, paraffin-embedded (FFPE) human tissue obtained in clinical trials of potential anti-angiogenic agents. Therefore, we developed colorimetric, dual-label immunohistochemical techniques for use on FFPE tissue, based on the use of single-stranded (ss) DNA and Ki-67 as markers of EC apoptosis and proliferation, respectively. Digital image analysis was used to obtain the total tumour microvessel density (MVD), from which the EC apoptosis index (AI) and proliferation index (PI) were derived manually as the number of positive ECs per vessel. Immunohistochemical measurement of EC apoptosis and proliferation was validated on human colorectal cancer liver metastases from a randomized, placebo-controlled trial of the selective cyclooxygenase-2 inhibitor rofecoxib. Proliferating and apoptotic ECs clustered in discrete areas of the tumour vasculature. ECAI (median [inter-quartile range, IQR] 0.0018 [0.0003-0.0064]) and ECPI (median [IQR] 0.0043 [0.002-0.014]) values were low and highly variable in tumours from both placebo- and rofecoxib-treated patients. Our novel dual-label immunohistochemical methods will be generally applicable in FFPE human cancer tissue and should prove invaluable for measuring the anti-angiogenic activity of experimental therapies in clinical trials. The low absolute level of and variability in EC apoptosis and proliferation detectable in human colorectal cancer liver metastases indicates that similar intervention studies using these end-points will need to ensure adequate size in order to be able to detect anti-angiogenic activity by immunohistochemical methods. © 2006 Springer Science + Business Media B.V.
引用
收藏
页码：193 / 200
页数：7
相关论文
共 17 条
  • [11] Walker J.A., Quirke P., Viewing apoptosis through a 'TUNEL, J Pathol, 195, pp. 275-276, (2001)
  • [12] Ramachandran A., Madesh M., Balasubramanian K.A., Apoptosis in the intestinal epithelium: Its relevance in normal and pathophysiological conditions, J Gastroenterol Hepatol, 15, pp. 109-120, (2000)
  • [13] Frankfurt O.S., Robb J.A., Sugarbaker E.V., Villa L., Monoclonal antibody to single-stranded DNA is a specific and sensitive cellular marker of apoptosis, Exp Cell Res, 226, pp. 387-397, (1996)
  • [14] Raut C.P., Nawrocki S., Lashinger L.M., Et al., Celecoxib inhibits angiogenesis by inducing endothelial cell apoptosis in human pancreatic tumor xenografts, Cancer Biol Ther, 3, pp. 1217-1224, (2004)
  • [15] Yokoi K., Kim S.-J., Thaker P., Et al., Induction of apoptosis in tumor-associated endothelial cells and therapy of orthotopic human pancreatic carcinoma in nude mice, Neoplasia, 7, pp. 696-704, (2005)
  • [16] De Jong K.P., Vermeulen P.B., Van Marck E., Boot M., Gouw A.S.H., Endothelial cell apoptosis in the context of quantification of angiogenesis in solid human adenocarcinomas: A novel double immunolabelling technique to identify endothelial cell apoptosis, Eur J Cancer, 42, pp. 97-100, (2006)
  • [17] Leahy K.M., Ornberg R.L., Wang Y., Zweifel B.S., Koki A.T., Masferrer J.L., Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo, Cancer Res, 62, pp. 625-631, (2002)
12